World's Best Scientists 2026 revealed!
Award Badge
Immunology
USA
2026

D-Index & Metrics

Immunology

D-Index
154
Citations
102789
World Ranking
109
National Ranking
69

Medicine

D-Index
154
Citations
102800
World Ranking
993
National Ranking
566

William W. Busse publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where William W. Busse sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 981 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

William W. Busse D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where William W. Busse sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 154 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Immunology in United States Leader Award
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

William W. Busse is affiliated with the University of Wisconsin-Madison in the United States and has contributed extensively to the field of medicine, with a particular focus on physiology, pulmonary and respiratory medicine, immunology, and immunology and allergy. Their research encompasses a wide range of topics, notably asthma and respiratory diseases, respiratory and cough-related research, IL-33, ST2, and ILC pathways, allergic rhinitis and sensitization, eosinophilic esophagitis, inhalation and respiratory drug delivery, and pediatric health and respiratory diseases.

Busse's recent publications include the following:

  • Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation, 2021, European Respiratory Journal
  • Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis, 2021, The Lancet Respiratory Medicine

Other notable recent papers within their collaborative network include:

  • Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2, 2020, Journal of Allergy and Clinical Immunology
  • Type 2 immunity in the skin and lungs, 2020, Allergy
  • Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial, 2022, The Lancet

William W. Busse has frequently collaborated with a number of co-authors, including Daniel J. Jackson, Leonard B. Bacharier, Gurjit K. Khurana Hershey, James E. Gern, and Meyer Kattan.

The scientist's work has been published extensively in prominent journals. The most frequent publication venues include:

  • Journal of Allergy and Clinical Immunology
  • The Journal of Allergy and Clinical Immunology In Practice
  • Annals of Allergy Asthma & Immunology
  • American Journal of Respiratory and Critical Care Medicine
  • Brain Behavior and Immunity

Busse's research contributions span over 300 published works in medicine, with significant specializations distributed as 117 publications in physiology, 78 in pulmonary and respiratory medicine, 43 in immunology, 34 in immunology and allergy, and 22 in surgery.

William W. Busse is recognized for their membership in the Association of American Physicians.

Best Publications

  • Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

    J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly

  • Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

    J. Bousquet;N. Khaltaev;A. A. Cruz;J. Denburg

  • Asthma. From bronchoconstriction to airways inflammation and remodeling.

    Jean Bousquet;Peter K. Jeffery;William W. Busse;Malcolm Johnson

  • Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program

    Wendy C. Moore;Deborah A. Meyers;Sally E. Wenzel;W. Gerald Teague

  • Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study.

    Eric D. Bateman;Homer A. Boushey;Jean Bousquet;William W. Busse

  • Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

    Mario Castro;Jonathan Corren;Ian D. Pavord;Jorge Maspero

  • An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.

    Helen K. Reddel;D. Robin Taylor;Eric D. Bateman;Louis-Philippe Boulet

  • Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

    J Mark FitzGerald;Eugene R Bleecker;Parameswaran Nair;Stephanie Korn

  • Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.

    William Busse;Jonathan Corren;Bobby Quentin Lanier;Margaret McAlary

  • Efficacy and safety of inhaled corticosteroids. New developments.

    Peter J. Barnes;Søren Pedersen;William W. Busse

  • Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children

    William W. Busse;Wayne J. Morgan;Peter J. Gergen;Herman E. Mitchell

  • Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program

    Wendy C. Moore;Eugene R. Bleecker;Douglas Curran-Everett;Serpil C. Erzurum

  • Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.

    Nicola A. Hanania;Sally Wenzel;Karin Rosén;Hsin-Ju Hsieh

  • Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma

    Jean Bousquet;Jean Bousquet;Eva Mantzouranis;Alvaro A. Cruz;Nadia Aït-Khaled

  • Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations

    Dara G. Torgerson;Dara G. Torgerson;Elizabeth J. Ampleford;Grace Y. Chiu;W. James Gauderman

  • Role of viral respiratory infections in asthma and asthma exacerbations

    William W Busse;Robert F Lemanske;James E Gern

  • A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.

    Patrick Flood-Page;Cheri Swenson;Isidore Faiferman;John Matthews

  • Effects of Treatment with Anti-immunoglobulin E Antibody Omalizumab on Airway Inflammation in Allergic Asthma

    Ratko Djukanović;Susan J. Wilson;Monica Kraft;Nizar N. Jarjour

  • Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.

    Jonathan A. Leff;William W. Busse;David Pearlman;Edwin A. Bronsky

  • Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial

    Unknown

  • Allergy, rhinitis, other respiratory diseases Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

    William Busse;Jonathan Corren;Bobby Quentin Lanier;Margaret McAlary

Frequent Co-Authors

Eugene R. Bleecker
Eugene R. Bleecker University of Arizona
Sally E. Wenzel
Sally E. Wenzel University of Pittsburgh
James E. Gern
James E. Gern University of Wisconsin–Madison
Stanley J. Szefler
Stanley J. Szefler University of Colorado Denver
Nizar N. Jarjour
Nizar N. Jarjour University of Wisconsin–Madison
Mario Castro
Mario Castro Washington University in St. Louis
Harold S. Nelson
Harold S. Nelson National Jewish Health
Serpil C. Erzurum
Serpil C. Erzurum Cleveland Clinic Lerner College of Medicine
Donald Y.M. Leung
Donald Y.M. Leung National Jewish Health
Eric D. Bateman
Eric D. Bateman University of Cape Town

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare degrees can open diverse career opportunities. Many students transition into nursing to apply their immunology knowledge in clinical settings. Programs like online BSN programs for non nurses provide a flexible pathway for individuals without prior nursing experience to quickly enter the field.

If you're looking to accelerate your nursing career, consider 12-month accelerated nursing programs that allow for fast-tracked education without compromising quality. These programs are designed for motivated students ready to meet the demands of an intensive curriculum.

For those exploring entry-level nursing roles, researching LPN schools easy to get into can be a practical starting point. Licensed Practical Nurses play a vital role in patient care, often working alongside immunology specialists.

Finally, advancing to advanced practice roles such as nurse practitioners is possible through programs identified by what is the easiest NP program. These offer specialized training that can complement an immunology background and expand career horizons.

Best Scientists Citing William W. Busse

Trending Scientists

Recently Published Articles